LianBio General and Administrative Expense
LianBio (LIANY) reported General and Administrative Expense of $17.28 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GeneralAndAdministrativeExpense · last filed 2023-11-13
- LianBio general and administrative expense for the quarter ending 2023-09-30 was $17.28M, a 6.09% increase year-over-year.
- LianBio general and administrative expense for the quarter ending 2023-06-30 was $15.59M, a 7.14% increase year-over-year.
- LianBio general and administrative expense for the quarter ending 2023-03-31 was $15.14M, a 5.91% decline year-over-year.
- LianBio general and administrative expense for the quarter ending 2022-12-31 was $18.67M, a 29.80% increase year-over-year.
- LianBio general and administrative expense for fiscal 2022 was $65.60M, a 77.88% increase from fiscal 2021.
- LianBio general and administrative expense for fiscal 2021 was $36.88M, a 163.72% increase from fiscal 2020.
- LianBio general and administrative expense for fiscal 2020 was $13.98M.
| Period end | General and Administrative Expense 3 month | General and Administrative Expense 6 month | General and Administrative Expense 9 month | General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2023-09-30 | $17.28M 10-Q · filed 2023-11-13 | $32.87M derived: sum of 2 quarters · filed 2023-11-13 | $48.01M 10-Q · filed 2023-11-13 | $66.68M derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-06-30 | $15.59M 10-Q · filed 2023-08-14 | $30.73M 10-Q · filed 2023-08-14 | $49.40M derived: sum of 3 quarters · filed 2023-08-14 | $65.69M derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-03-31 | $15.14M 10-Q · filed 2023-05-11 | $33.81M derived: sum of 2 quarters · filed 2023-05-11 | $50.10M derived: sum of 3 quarters · filed 2023-11-13 | $64.65M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-12-31 | $18.67M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $34.96M derived: sum of 2 quarters · filed 2023-11-13 | $49.51M derived: sum of 3 quarters · filed 2023-11-13 | $65.60M 10-K · filed 2023-03-28 |
| 2022-09-30 | $16.29M 10-Q · filed 2023-11-13 | $30.84M derived: sum of 2 quarters · filed 2023-11-13 | $46.93M 10-Q · filed 2023-11-13 | $61.31M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $14.55M 10-Q · filed 2023-08-14 | $30.64M 10-Q · filed 2023-08-14 | $45.02M derived: sum of 3 quarters · filed 2023-08-14 | $53.91M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $16.09M 10-Q · filed 2023-05-11 | $30.47M derived: sum of 2 quarters · filed 2023-05-11 | $39.36M derived: sum of 3 quarters · filed 2023-05-11 | $45.82M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $14.38M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $23.27M derived: sum of 2 quarters · filed 2023-03-28 | $29.73M derived: sum of 3 quarters · filed 2023-03-28 | $36.88M 10-K · filed 2023-03-28 |
| 2021-09-30 | $8.89M 10-Q · filed 2022-11-10 | $15.35M derived: sum of 2 quarters · filed 2022-11-10 | $22.50M 10-Q · filed 2022-11-10 | $28.99M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $6.46M 10-Q · filed 2022-08-11 | $13.61M 10-Q · filed 2022-08-11 | $20.10M derived: sum of 3 quarters · filed 2022-08-11 | $22.23M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $7.15M 10-Q · filed 2022-05-12 | $13.64M derived: sum of 2 quarters · filed 2022-05-12 | $15.77M derived: sum of 3 quarters · filed 2022-05-12 | |
| 2020-12-31 | $6.49M derived: 10-K 12 month − 10-Q/A 9 month · filed 2022-03-31 | $8.62M derived: sum of 2 quarters · filed 2022-03-31 | $13.98M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $2.13M 10-Q/A · filed 2022-01-10 | $7.49M 10-Q/A · filed 2022-01-10 |